Policy options to deal with high-cost medicines – survey with European policy-makers
Main Authors: | Nina Zimmermann, Sabine Vogler, Hanne Bak Pedersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2015-12-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1186/2052-3211-8-S1-P8 |
Similar Items
-
Reimbursement measures in European countries – findings of a bibliometric literature review
by: Sabine Vogler, et al.
Published: (2015-12-01) -
Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference
by: Sabine Vogler, et al.
Published: (2021-12-01) -
Prioritization of sustainable urban land use and transport policy measures for a small-town area in a developing country
by: Prak Mesa, et al.
Published: (2023-05-01) -
Managing new premium-priced medicines in Europe
by: Govin Permanand, et al.
Published: (2015-12-01) -
Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
by: Szczepan Jakubowski, et al.
Published: (2024-03-01)